From: Discovering associations between adverse drug events using pattern structures and ontologies
Rule | S 1 | S 2 |
---|---|---|
{ 〈{Anilides}, {Thrombocytopenia, unsp.} 〉, | 9 | 326 |
〈{Antithrombotic agents}, {Thrombocytopenia, unsp.} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉} | ||
{ 〈{Serotonin (5HT3) antagonists}, {Thrombocytopenia, unsp.} 〉, | 8 | 256 |
〈{Anilides}, {Thrombocytopenia, unsp.} 〉, | ||
〈{Antithrombotic agents}, {Thrombocytopenia, unsp.} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉} | ||
{ 〈{Proton pump inhibitors}, {Thrombocytopenia, unsp.} 〉, | 9 | 176 |
〈{Antithrombotic agents}, {Thrombocytopenia, unsp.} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉, | ||
〈{Drugs for peptic ulcer and GORD}, {Anemia, unsp.} 〉} | ||
{ 〈{Proton pump inhibitors}, {Thrombocytopenia, unsp.} 〉, | 8 | 157 |
〈{Anilides}, {Thrombocytopenia, unsp.} 〉, | ||
〈{Antithrombotic agents}, {Thrombocytopenia, unsp.} 〉} | ||
→ { 〈{Drugs for peptic ulcer and GORD}, {Anemia, unsp.} 〉, | ||
〈{Opioids}, {Anemia, unsp.} 〉} | ||
{ 〈{Benzothiazepine derivatives}, {Congestive heart failure, unsp.} 〉} | 10 | 129 |
→ { 〈{Drugs for peptic ulcer and GORD}, {Atrial fibrillation} 〉} | ||
{ 〈{Drugs for peptic ulcer and GORD}, {Atrial fibrillation} 〉, | 8 | 66 |
〈{ACE inhibitors, plain}, {Atrial fibrillation} 〉, | ||
〈{Anilides}, {Atrial fibrillation} 〉} | ||
→ { 〈{Serotonin (5HT3) antagonists}, {Heart failure} 〉, | ||
〈{Drugs for peptic ulcer and GORD}, {Congestive heart failure, unsp.} 〉} | ||
{ 〈{Serotonin (5HT3) antagonists}, {Atrial fibrillation} 〉, | 8 | 64 |
〈{Drugs for peptic ulcer and GORD}, {Atrial fibrillation} 〉, | ||
〈{ACE inhibitors, plain}, {Atrial fibrillation} 〉} | ||
→ { 〈{Electrolyte solutions}, {Congestive heart failure, unsp.} 〉, | ||
〈{Osmotically acting laxatives}, {Heart failure} 〉} | ||
{ 〈{Proton pump inhibitors}, {Thrombocytopenia, unsp.} 〉, | 10 | 49 |
〈{Anilides}, {Thrombocytopenia, unsp.} 〉, | ||
〈{Glucocorticoids}, {Thrombocytopenia, unsp.} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉, | ||
〈{Drugs for peptic ulcer and GORD}, {Anemia, unsp.} 〉} | ||
{ 〈{Proton pump inhibitors}, {Congestive heart failure, unsp.} 〉, | 9 | 37 |
〈{Antithrombotic agents, Anilides, Opium alkaloids and derivatives}, {Heart failure} 〉, | ||
〈{Anilides}, {Congestive heart failure, unsp.} 〉, 〈{Anxiolytics}, {Heart failure} 〉, | ||
〈{Electrolyte solutions}, {Congestive heart failure, unsp.} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉} | ||
{ 〈{Sulfonamides, plain}, {Congestive heart failure, unsp.} 〉, | 8 | 33 |
〈{Antithrombotic agents, Anilides, Opium alkaloids and derivatives}, | ||
{Heart failure} 〉, | ||
〈{Proton pump inhibitors}, {Congestive heart failure, unsp.} 〉, | ||
〈{Anxiolytics}, {Heart failure} 〉, | ||
〈{Anilides}, {Congestive heart failure, unsp.} 〉, | ||
〈{Electrolyte solutions}, {Congestive heart failure, unsp.} 〉, | ||
〈{Sulfonamides, plain, R05D}, {Heart failure} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉} | ||
{ 〈{Anilides, Opium alkaloids and derivatives, Proton pump inhibitors}, {Heart failure} 〉, | 8 | 31 |
〈{Anilides, Proton pump inhibitors}, {Congestive heart failure, unsp.} 〉, | ||
〈{Antithrombotic agents, Anilides, Opium alkaloids and derivatives}, | ||
{Heart failure} 〉, | ||
〈{Anxiolytics}, {Congestive heart failure, unsp.} 〉, | ||
〈{Electrolyte solutions}, {Congestive heart failure, unsp.} 〉} | ||
→ { 〈{Opioids}, {Anemia, unsp.} 〉} |